90 related articles for article (PubMed ID: 38618958)
1. Merkel cell polyomavirus-specific and CD39
Ryu H; Bi TM; Pulliam TH; Sarkar K; Church CD; Kumar N; Mayer-Blackwell K; Jani S; Ramchurren N; Hansen UK; Hadrup SR; Fling SP; Koelle DM; Nghiem P; Newell EW
Cell Rep Med; 2024 Feb; 5(2):101390. PubMed ID: 38340724
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-intrinsic PD-1 promotes Merkel cell carcinoma growth by activating downstream mTOR-mitochondrial ROS signaling.
Martins C; Rasbach E; Heppt MV; Singh P; Kulcsar Z; Holzgruber J; Chakraborty A; Mucciarone K; Kleffel S; Brandenburg A; Hoetzenecker W; Rahbari NN; DeCaprio JA; Thakuria M; Murphy GF; Ramsey MR; Posch C; Barthel SR; Schatton T
Sci Adv; 2024 Jan; 10(3):eadi2012. PubMed ID: 38241371
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-Instructed Photoactivatable Supramolecular Antigens on Cancer Cell Membranes for Precision-Controlled T-Cell-Based Cancer Immunotherapy.
Ding Y; Zhang S; Li W; Chen X; Li J; Zhang X; Zhang Z; Hu Y; Yang Z; Hu ZW; Shen X
Nano Lett; 2024 Jun; ():. PubMed ID: 38838340
[TBL] [Abstract][Full Text] [Related]
4. Polyomavirus-positive Merkel cell carcinoma: the beginning of the beginning.
Wong MK; Yee C
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618960
[TBL] [Abstract][Full Text] [Related]
5. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development.
Tabachnick-Cherny S; Pulliam T; Church C; Koelle DM; Nghiem P
Mol Carcinog; 2020 Jul; 59(7):807-821. PubMed ID: 32219902
[TBL] [Abstract][Full Text] [Related]
6. Insights into anti-tumor immunity
Jani S; Church CD; Nghiem P
Front Immunol; 2023; 14():1172913. PubMed ID: 37287968
[TBL] [Abstract][Full Text] [Related]
7. T antigen-specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma.
Hansen UK; Church CD; Carnaz Simões AM; Frej MS; Bentzen AK; Tvingsholm SA; Becker JC; Fling SP; Ramchurren N; Topalian SL; Nghiem PT; Hadrup SR
J Clin Invest; 2024 Jan; 134(8):. PubMed ID: 38618958
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma.
Church C; Pulliam T; Longino N; Park SY; Smythe KS; Makarov V; Riaz N; Jing L; Amezquita R; Campbell JS; Gottardo R; Pierce RH; Choi J; Chan TA; Koelle DM; Nghiem P
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36252564
[TBL] [Abstract][Full Text] [Related]
9. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
[TBL] [Abstract][Full Text] [Related]
10. MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series.
Ugurel S; Spassova I; Wohlfarth J; Drusio C; Cherouny A; Melior A; Sucker A; Zimmer L; Ritter C; Schadendorf D; Becker JC
Cancer Immunol Immunother; 2019 Jun; 68(6):983-990. PubMed ID: 30993371
[TBL] [Abstract][Full Text] [Related]
11. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8
Jing L; Ott M; Church CD; Kulikauskas RM; Ibrani D; Iyer JG; Afanasiev OK; Colunga A; Cook MM; Xie H; Greninger AL; Paulson KG; Chapuis AG; Bhatia S; Nghiem P; Koelle DM
Cancer Immunol Res; 2020 May; 8(5):648-659. PubMed ID: 32179557
[TBL] [Abstract][Full Text] [Related]
12. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
Miller NJ; Church CD; Fling SP; Kulikauskas R; Ramchurren N; Shinohara MM; Kluger HM; Bhatia S; Lundgren L; Cheever MA; Topalian SL; Nghiem P
J Immunother Cancer; 2018 Nov; 6(1):131. PubMed ID: 30482247
[TBL] [Abstract][Full Text] [Related]
13. TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
Tvingsholm SA; Frej MS; Rafa VM; Hansen UK; Ormhøj M; Tyron A; Jensen AWP; Kadivar M; Bentzen AK; Munk KK; Aasbjerg GN; Ternander JSH; Heeke C; Tamhane T; Schmess C; Funt SA; Kjeldsen JW; Kverneland AH; Met Ö; Draghi A; Jakobsen SN; Donia M; Marie Svane I; Hadrup SR
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586765
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer.
Marcos Rubio A; Everaert C; Van Damme E; De Preter K; Vermaelen K
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37536935
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
Rohaan MW; Borch TH; van den Berg JH; Met Ö; Kessels R; Geukes Foppen MH; Stoltenborg Granhøj J; Nuijen B; Nijenhuis C; Jedema I; van Zon M; Scheij S; Beijnen JH; Hansen M; Voermans C; Noringriis IM; Monberg TJ; Holmstroem RB; Wever LDV; van Dijk M; Grijpink-Ongering LG; Valkenet LHM; Torres Acosta A; Karger M; Borgers JSW; Ten Ham RMT; Retèl VP; van Harten WH; Lalezari F; van Tinteren H; van der Veldt AAM; Hospers GAP; Stevense-den Boer MAM; Suijkerbuijk KPM; Aarts MJB; Piersma D; van den Eertwegh AJM; de Groot JB; Vreugdenhil G; Kapiteijn E; Boers-Sonderen MJ; Fiets WE; van den Berkmortel FWPJ; Ellebaek E; Hölmich LR; van Akkooi ACJ; van Houdt WJ; Wouters MWJM; van Thienen JV; Blank CU; Meerveld-Eggink A; Klobuch S; Wilgenhof S; Schumacher TN; Donia M; Svane IM; Haanen JBAG
N Engl J Med; 2022 Dec; 387(23):2113-2125. PubMed ID: 36477031
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
